((2R,3S,5R)-3-acetoxy-5-(2,4-dioxo-5-(phenylethynyl)-3,4-dihydropyrimidin-1(2H)-yl)tetrahydrofuran-2-yl)methyl acetate

 化学構造式
943446-57-9
CAS番号.
943446-57-9
化学名:
别名:
英語名:
((2R,3S,5R)-3-acetoxy-5-(2,4-dioxo-5-(phenylethynyl)-3,4-dihydropyrimidin-1(2H)-yl)tetrahydrofuran-2-yl)methyl acetate
英語别名:
Uridine, 2'-deoxy-5-(2-phenylethynyl)-, 3',5'-diacetate;((2R,3S,5R)-3-acetoxy-5-(2,4-dioxo-5-(phenylethynyl)-3,4-dihydropyrimidin-1(2H)-yl)tetrahydrofuran-2-yl)methyl acetate
CBNumber:
CB29996236
化学式:
C21H20N2O7
分子量:
412.39
MOL File:
943446-57-9.mol

((2R,3S,5R)-3-acetoxy-5-(2,4-dioxo-5-(phenylethynyl)-3,4-dihydropyrimidin-1(2H)-yl)tetrahydrofuran-2-yl)methyl acetate 物理性質

比重(密度) :
1.39±0.1 g/cm3(Predicted)
酸解離定数(Pka):
8.25±0.10(Predicted)

安全性情報

((2R,3S,5R)-3-acetoxy-5-(2,4-dioxo-5-(phenylethynyl)-3,4-dihydropyrimidin-1(2H)-yl)tetrahydrofuran-2-yl)methyl acetate 価格

メーカー 製品番号 製品説明 CAS番号 包装 価格 更新時間 購入

((2R,3S,5R)-3-acetoxy-5-(2,4-dioxo-5-(phenylethynyl)-3,4-dihydropyrimidin-1(2H)-yl)tetrahydrofuran-2-yl)methyl acetate 化学特性,用途語,生産方法

((2R,3S,5R)-3-acetoxy-5-(2,4-dioxo-5-(phenylethynyl)-3,4-dihydropyrimidin-1(2H)-yl)tetrahydrofuran-2-yl)methyl acetate 上流と下流の製品情報

原材料

準備製品


((2R,3S,5R)-3-acetoxy-5-(2,4-dioxo-5-(phenylethynyl)-3,4-dihydropyrimidin-1(2H)-yl)tetrahydrofuran-2-yl)methyl acetate 生産企業

Global( 5)Suppliers
名前 電話番号 電子メール 国籍 製品カタログ 優位度
NewCan Biotech Limited
+86-0571-86912261 +8613735419629
sales@newcanbio.com China 9980 58
Zhengzhou Chemprize Biotech Co., Ltd.
+86-86-0371-56768238 +8615981919713
sales@chemprize.com China 297 58
Hangzhou FuRun Pharmaceutical Technology Co., Ltd 19975279805
1900830611@qq.com China 956 58
NewCan Biotech Limited +86-0571-86912261 +86-15658003402
sales@newcanbio.com China 330 58
Zhengzhou Chemprize Biotech Co., Ltd. 15981919713
sales@chemprize.com China 408 58

  • 943446-57-9
  • ((2R,3S,5R)-3-acetoxy-5-(2,4-dioxo-5-(phenylethynyl)-3,4-dihydropyrimidin-1(2H)-yl)tetrahydrofuran-2-yl)methyl acetate
  • Uridine, 2'-deoxy-5-(2-phenylethynyl)-, 3',5'-diacetate
Copyright 2017 © ChemicalBook. All rights reserved